ࡱ> ~W  !#"$DE&'()*+,-./0123456789:;<=>?@ABCGFHIVXKLMNOPQRSTUk}YZ[\]^j`abcdefghimlnopqrtsuwvxyz{|Root Entry` FNUE__nameid_version1.0( !UE&UE__substg1.0_00020102*__substg1.0_00030102* ,/0367:;>@DHIJMNOQXY]bcdefghijklmnopqrstuvwxyz{|}~Pc ̜_ FAAZk 3z.B{yᩎTk?@0GZ+##]h2GULN3Fo:0FJZx0 dx   (     P  RTX,d   < P p   @!x"#$@%&'@(l)*+0 ,d - . /( 0` 1 2 3 48 5T 6 7L 8 9 : ;P < = >L?@APB|CDE` FGHIP JKL M(N@ OpP QRSۚE b 0CC Mxja)$(86D=D\N/l# <=% J__substg1.0_00040102*__substg1.0_10000102* __substg1.0_10010102*(__substg1.0_10020102* ,BigFunnelCorrelationId0ExchangeApplicationFlagsKeywordsHasQuotedText&IsQuotedTextChanged.LastIndexingAttemptTime,HeaderBodyFragmentList^X-MS-Exchange-Organization-ATPSafeLinks-MsgData2CurrentMessageSafetyFlags NetworkMessageId$IsPartiallyIndexed<BigFunnelCompleteIndexingStart8BigFunnelCompleteIndexingEnd DetectedLanguage6ConversationIndexTrackingEx$ClassificationType>OriginalInferenceClassificationHGriffinInferenceClassificationResult:InferenceClassificationResultBGriffinTriageHeuristicsFeatureSet4TriageHeuristicsFeatureSet.EntityExtraction/Url1.0>EntityExtraction/EmbeddedUrl1.0,ClassificationLastScan,LatestMessageWordCountIsSignedIsReadReceiptJX-Microsoft-Antispam-Mailbox-DeliveryBX-Microsoft-Antispam-Message-Info4InferenceMessageIdentifier2ConversationContributions,ConversationWasFocusedJx-ms-exchange-organization-authsourceBx-ms-exchange-organization-authasdx-ms-exchange-organization-originalclientipaddressdx-ms-exchange-organization-originalserveripaddress,x-ms-publictraffictype&ClassificationCount0ClassificationConfidence@ComposedClassificationAttributesFDetailedClassificationSchemeEnabled.ClassificationContextV2 IsExternalSenderFEntityExtraction/ExtractLanguage1.0NEntityExtraction/KeyPhraseExtraction2.04InTransitMessageCorrelator:InferenceClassificationReasonBInferenceClassificationTrackingExDarwin/Url2.0,FocusedInboxModelScorereceived-spfrX-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Data|X-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Signature6x-forefront-antispam-report,authentication-results4x-ms-traffictypediagnosticZx-ms-exchange-crosstenant-originalarrivaltimeTx-ms-exchange-crosstenant-fromentityheader8x-ms-exchange-crosstenant-idbx-ms-exchange-transport-crosstenantheadersstampedXx-ms-exchange-crosstenant-network-message-idNx-ms-exchange-transport-endtoendlatencyNx-ms-office365-filtering-correlation-id(x-microsoft-antispamNx-ms-exchange-processed-by-bccfolderingHx-ms-exchange-crosstenant-authsource@x-ms-exchange-crosstenant-authas8AntispamSafeLinksWrappedUrlsDx-ms-exchange-atpmessageproperties,x-eopattributedmessage8x-eoptenantattributedmessage@AntispamSafelinksIsIntraOrgEmailBodyLanguages&AttachmentLanguagesDX-MS-Exchange-Organization-BUABFLCIsNotToMe,EntityExtraction/IsM2HFIFeatureSetVEntityExtraction/KPEM2HItemProcessorSuccess__substg1.0_10030102*(__substg1.0_10040102*__substg1.0_10050102*__substg1.0_10060102* p + 槥 0)u%*LD&әVX Qͼ^3,E5 7R! 6 D6C;T,B -H__substg1.0_10070102*__substg1.0_10080102* __substg1.0_10090102*__substg1.0_100C0102*__substg1.0_100D0102*__substg1.0_100E0102* __substg1.0_100F0102*__substg1.0_10100102*GS ')* a O-?l "Z,&#Դ>j Jڱ+?PD d7#%h /jK  uK V'j99 buTQKBzihE bIF a((ѽS3__substg1.0_10110102* __substg1.0_10120102* __substg1.0_10130102*(__substg1.0_10140102*__substg1.0_10150102* __substg1.0_10160102*!__substg1.0_10170102*"__substg1.0_10180102*#;M.d߻cA Q Rb. h2S 1V (l+~b:5! ™4 yz  .}=2I 'u%4y?__substg1.0_10190102*$__substg1.0_101A0102*%__substg1.0_101B0102*&__substg1.0_101C0102* ' __substg1.0_101D0102*!(__substg1.0_101E0102*)__substg1.0_001A001F*#*__substg1.0_0037001F*+~?v FNG%P@IPM.NoteIRAS Project ID 316755. HRA and HCRW Approval for the AmendmentSMTP:NOREPLY@HARP.ORG.UKܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C__substg1.0_003B0102*"&-__substg1.0_003D001F*__substg1.0_003F0102*%'.__substg1.0_0040001F*1875F5632DDE22D7C-SISSIS, Resource+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukamendments@hra.nhs.ukܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS__substg1.0_00410102*$,2v__substg1.0_0042001F*4*__substg1.0_00430102*)+5__substg1.0_0044001F*8SIS, Resource~z+nTamendments@hra.nhs.ukSMTPamendments@hra.nhs.ukamendments@hra.nhs.ukEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23S__substg1.0_004F0102**.9__substg1.0_0050001F*<*__substg1.0_00510102*-/=|__substg1.0_00520102*?|PDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSMTPnoreply@harp.org.ukIRAS Project ID 316755. HRA and HCRW Approval for the Amendment7ğ_6M\yXEX/O=EXCHANGELABS/OU=EXCHANGE ADMI__substg1.0_0064001F*(8A__substg1.0_0065001F*B&__substg1.0_0070001F*13C~__substg1.0_00710102*E__substg1.0_0075001F*26F__substg1.0_0076001F*G__substg1.0_0077001F*57K__substg1.0_0078001F*LNISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS__substg1.0_007D001F*4<%<__substg1.0_0C190102*Pv__substg1.0_0C1A001F*9;R*__substg1.0_0C1D0102*SReceived: from PAXPR01MB8598.eurprd01.prod.exchangelabs.com (2603:10a6:102:232::5) by VI1PR01MB4397.eurprd01.prod.exchangelabs.com with HTTPS; Fri, 27 Jun 2025 07:47:44 +0000 Received: from AM0PR08CA0028.eurprd08.prod.outlook.com (2603:10a6:208:d2::41) by PAXPR01MB8598.eurprd01.prod.exchangelabs.com (2603:10a6:102:232::5) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8880.15; Fri, 27 Jun 2025 07:47:40 +0000 Received: from AMS1EPF00000046.eurprd04.prod.outlook.com (2603:10a6:208:d2:cafe::af) by AM0PR08CA0028.outlook.office365.com (2603:10a6:208:d2::41) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.8880.17 via Frontend Transport; Fri, 27 Jun 2025 07:47:40 +0000 Authentication-Results: spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=bestguesspass action=none header.from=harp.org.uk;compauth=pass reason=109 Received-SPF: Pass (protection.outlook.com: domain of harp.org.uk designates 5.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C Received: from cpanel.harp.org.uk (5.101.140.163) by AMS1EPF00000046.mail.protection.outlook.com (10.167.16.43) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8880.14 via Frontend Transport; Fri, 27 Jun 2025 07:47:39 +0000 Received: from [178.22.160.68] (port=8239 helo=HRA-HARPAPP02) by cpanel.harp.org.uk with esmtpa (Exim 4.98.1) (envelope-from <noreply@harp.org.uk>) id 1uV3oC-0000000044T-2nZ0; Fri, 27 Jun 2025 08:47:39 +0100 MIME-Version: 1.0 From: "amendments@hra.nhs.uk" <noreply@harp.org.uk> To: mark.wilson19@nhs.net, k.boland@imperial.ac.uk Cc: sis@warwick.ac.uk Reply-To: amendments@hra.nhs.uk Date: 27 Jun 2025 08:47:39 +0100 Subject: IRAS Project ID 316755. HRA and HCRW Approval for the Amendment Content-Type: text/html; charset=utf-8 Content-Transfer-Encoding: base64 X-AntiAbuse: This header was added to track abuse, please include it with any abuse report X-AntiAbuse: Primary Hostname - cpanel.harp.org.uk X-AntiAbuse: Original Domain - warwick.ac.uk X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12] X-AntiAbuse: Sender Address Domain - harp.org.uk X-Get-Message-Sender-Via: cpanel.harp.org.uk: authenticated_id: noreply@harp.org.uk X-Authenticated-Sender: cpanel.harp.org.uk: noreply@harp.org.uk X-Source: X-Source-Args: X-Source-Dir: Message-ID: <c173b12d-fda0-4e6f-a8d1-9fd37baea654@AMS1EPF00000046.eurprd04.prod.outlook.com> Return-Path: noreply@harp.org.uk X-MS-Exchange-Organization-ExpirationStartTime: 27 Jun 2025 07:47:39.7694 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 09588ace-6a12-4e59-0987-08ddb54ee43c X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 09bacfbd-47ef-4465-9265-3546f2eaf6bc:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: AMS1EPF00000046:EE_|PAXPR01MB8598:EE_|VI1PR01MB4397:EE_ X-MS-Exchange-Organization-AuthSource: AMS1EPF00000046.eurprd04.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 09588ace-6a12-4e59-0987-08ddb54ee43c X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:3;ARA:13230040|12012899012|2092899012|3072899012|8096899003|13003099007; X-Forefront-Antispam-Report: CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFS:(13230040)(12012899012)(2092899012)(3072899012)(8096899003)(13003099007);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 27 Jun 2025 07:47:39.7022 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 09588ace-6a12-4e59-0987-08ddb54ee43c X-MS-Exchange-CrossTenant-Id: 09bacfbd-47ef-4465-9265-3546f2eaf6bc X-MS-Exchange-CrossTenant-AuthSource: AMS1EPF00000046.eurprd04.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAXPR01MB8598 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.8219555 X-MS-Exchange-Processed-By-BccFoldering: 15.20.8857.014 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930097)(140003)(1420198); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?ikdqhX2L45IUxDY719Cnnrazv6Lln6STFJqjNaReyJFvCoXxRveNODnFp/WT?= =?us-ascii?Q?Aj0E/ZvBtMJyNOyzTx9LF44RhZWGYjEC3otUSNRcN8AANiwkq/93iKOyn4Yz?= =?us-ascii?Q?ttAkGBu+nJ1KXb5P93Ip/D/3kI3gHAAp5AIRK6hOX1FimzbjjDco2X/5+VtX?= =?us-ascii?Q?f0BnQEMLV6mRSZyI9y60Qw2PmKjLvbBHBggZaIUHZGiBVyB2HihK8v5aUVrg?= =?us-ascii?Q?ad4uNhXj8PeBoUcFiKH4EH/mQkCm7f1jTArlkGsdgLIqhi7ME2FWQWp2YTBy?= =?us-ascii?Q?6wE4/7pOjJM8hnoBPipBPRTcYlY0R/aG+PYNI0ZqReOgaPtPuHnz0NS4EXpU?= =?us-ascii?Q?3KvwpYjBgcoqHFSaF2bOf1sNLqoqPtCjXDVFnARjO570LqOThaq2XL3j5mU4?= =?us-ascii?Q?uEU/TTMZEUbcwnc3Pc9p/ONVrA4il4Be5U3mxwYR9ZU+zYYCqsix4pm6S1Uo?= =?us-ascii?Q?EPL11EVbBILZgfd/nAUoTV40A4wBv/NMNusx3CZ3buDmL7344yZnQmWEf1Tl?= =?us-ascii?Q?bbduTiPf0Ra2+jxsfOWMLJToWVXEW8tJ1e2OGcyKwmX7Q5h5Mqeav7orRAJD?= =?us-ascii?Q?bpbpGmm72zTCuv7cl3yb/EC0HQC8Zq0CuEWBzX3Xuwcth097/ba7i2kCAyxa?= =?us-ascii?Q?WhOWdnqW2CUfogndc6M6BkBchq6wgN3834CLERdGZu0UW4r3svplZnWyuX4F?= =?us-ascii?Q?Hvf3zBV6D6UhOKqXC2sQYqKITkjDcD585NGZLEKjw4ysnis6yrgwrmhrG4sm?= =?us-ascii?Q?IEo41s0kzcbRV6kNzs/GVO34xcVoXxEVm7ISWJCJkoVa63cTk3Kb83wD8XCj?= =?us-ascii?Q?IxjL6kRj4xA3kme2JLfmZBqhwuJynUNDngW+cChwJQFXJodw2xbDZCez3QEA?= =?us-ascii?Q?F2T4lgzNhWLgZsJEwsz2z95YeNsIZcDxidA68kHmL2qoOlonBOFB031trlFw?= =?us-ascii?Q?UTlTq91+TsJo15PavPeCX5b6gZPIeDKNAsHBYN3afdRNl0s+nXxSCd5/AC/r?= =?us-ascii?Q?lKgZDcjSlvD72LGTzKG6+04g8fih0ZhOThjkVH354rlfAm7ZWx/gsd20G9W1?= =?us-ascii?Q?ibKENSLWIBHfoUPapl+rJ57IAaQR+b6VoZmXK/0PM9QSmC4XbCLocdvsFrr0?= =?us-ascii?Q?VKflKlzBNIP0zwNVsdnm7dr6BFwpARyn/12STwcfqfQ7OMs/Z/5vwaY4xEN5?= =?us-ascii?Q?wzjr+frv1LSP/6HUejYGhvKosj6QPsBSMSwOiXIFD1ANpVJ4ZwIvcXXESePN?= =?us-ascii?Q?z5KWxpF6TIFQ6/Hk17LRXzltw0gUBox0C2hMvlngOQqx9ugTuvXLhxTH8YHv?= =?us-ascii?Q?WQPBSWXE0aFUyQbFBcZtqideeFtQHA9fg+ZdyWIpRQc5V9DNTpxAcpyL1PDv?= =?us-ascii?Q?IjwhRkaMFB9+KuZ2BbxdVrRnFYw6vGlC6XBgL+te7m2H94cyMdc3W4Kfif2k?= =?us-ascii?Q?nAfDqkKy0oVmtWy05bTUzlHFLSOgeLBiOEUA9K51AFUca2nn0LOlLY6haKH9?= =?us-ascii?Q?KuuERYMmS5iT2ovrhvPOi9KsGZ7t5P9a+rgDrZI+i24e08ue/dSS3q89z/QK?= =?us-ascii?Q?WdKiJrqJ85TBH+f1JajVWRn1TBh2mHb4FW4VYFb9CcKCUuTygVNA7M+Yw7hl?= =?us-ascii?Q?m0z4mWcdpeiNlqU3+TfSZG1ITQRnRwdWmx+C3eNTssaULTiZvCGB7yrQPz3v?= =?us-ascii?Q?MB1hURMl1UTBNsZSH99+4BrGDi6UdUP9VD+uzKCfTmN578xOLCixgSzv+tPI?= =?us-ascii?Q?moafUIrMh9izWK0l2NvKm79h+ij+0xU+DmQAFggl4VhOTjrnNG/8t1wcKEtA?= =?us-ascii?Q?/+V+E49ifaKtPh1TyynaCDoD59+jPkXKjj35eEzywW9a6SfUDxsSNY1sct05?= =?us-ascii?Q?lZTZFFLPXYWQslaX8+8eroAwQUgTuJ4co6aio40r7YCEnt4ky7PgjDbVzyJI?= =?us-ascii?Q?psKOqNbo+2VF1kJXcudSrCV5oMcIRP7iNwRBzZgm6s6EJEAYpEDclD2u/GVd?= =?us-ascii?Q?djq7e2Ql3FP6NKN4OuLYijsjxdHy3Uka43A2WS4R9P42drw/loanx36wajv2?= =?us-ascii?Q?Xoo1I4obXWdd06h/luKdDzKmmmH4Y76ntMGt4/h4s96LnedsjVkJ0kgXTlLh?= =?us-ascii?Q?VUrDmwQnjRsTE1fw2BBlY++kVV1dQ68bUSUCtIIbYBWRKcTrSV1eXiyw/JVH?= =?us-ascii?Q?pRbTM6u7UTvIqiwWFHfE4eq7nePayukaurVUrjTfymbvRnXQr7e15Zzfb+bJ?= =?us-ascii?Q?IuJty9FJpqSkJ7U9tYevrj9SOJ5QTJVdjlTtxaPTXg=3D=3D?= +nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukamendments@hra.nhs.ukSMTP:NOREPLY@HARP.ORG.UKSMTPnoreply@harp.org.ukSIS, ResourceWILSON, Mark (IMPERIAL COLLEGE H__substg1.0_0C1E001F*:>T__substg1.0_0C1F001F*U&__substg1.0_0E02001F*=?__substg1.0_0E03001F*V__substg1.0_0E04001F*0PW__substg1.0_0E05001F*Z __substg1.0_0E0B0102*AC[.__substg1.0_0E1D001F*\~EALTHCARE NHS TRUST); k.boland@imperial.ac.ukInboxf͛/Z {.qhLƳA?" *KIRAS Project ID 316755. HRA and HCRW Approval for the AmendmentRMj7q8Q[@5k,__substg1.0_0E4C0102*BF^__substg1.0_0E590102*___substg1.0_0F030102*EG`__substg1.0_1000001F*J_6M\yX$o4LZFu^(a fbidccpg1252Rhtml1 ch set0 mP2ý2 } ; b19 _ 2s 5 843K9%p* atP`so Ex1nRvrtPnt  d R I\vwk d5"@0 r!Rbkmks BM_BEGIN}$Fp8g64&<"!tp-equiv=" !0-Tyxpe"!2*")!xt/"3!0D=W#*o#-"(tit#>SE56 P(App`v@)0'9.Tem Q}! /@ p !2fi ` HRA .Uw!a# 2!t. Please contact amendments@hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Famendments%40hra.nhs.uk%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C09588ace6a124e59098708ddb54ee43c%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638866072648404875%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Y52DrrJmioj46EPjDH1v1Kz2frPy0%2F8jnxcG41CnXNI%3D&reserved=0> for any queries relating to the assessment of this amendment. Kind regards Ashley Totenhofer Health Research Authority 2nd Floor | 2 Redman Place | Stratford | London | E20 1JQ E.amendments@hra.nhs.uk<mailto:amendments@hra.nhs.uk> W. www.hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C09588ace6a124e59098708ddb54ee43c%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638866072648428526%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=%2Bbc7EZxgqXu89Q2Ur5oeWa31%2Frh1YskgXGrzyq6W5Tg%3D&reserved=0> Sign up to receive our newsletter HRA Latest<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2Fabout-us%2Fhra-latest%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C09588ace6a124e59098708ddb54ee43c%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638866072648452223%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=3J31h51F3%2BGrtwt54yJEjS7LSbNLi3%2FFoczUf8fqy6c%3D&reserved=0> __substg1.0_10090102*DLa(__substg1.0_10130102*___substg1.0_1015001F*IK~__substg1.0_1035001F*lI e-(ig:2 px+-f{2y545zRe5110;*v4ak)pp P*8 28)EN-G>B* -4"tr9a(p>&  f$W\957 ҳ&F D(P`f ,ln,'/P<$U&/(B ?$(B-p;"3dth7a5cm+4#55R - `^pp5H7dax-mc43GFCMH_IkL)1-R3<E J275`-R!FL50%GhQJ)e#c!OJ( `%@U;O%@` Ax Xw 00,@ZBbps ;rhJMx4428[88. 2sb\0@ Vw= 0>I0?jUq`D:@}SXB(brAx=4bD_( '2DAz[fERSWC3>31670cAefghij2Rn]EYtPOQ_klTUVWb/YPZ?P[O\_oO^?"Sh tu32aOc?r_e_tuvw?kmnop 1qIm` 4`si (SIS)r/O_oy_zo{|}~ρYZoߛ?"A2&o.@p R_?OϚ/? Ju5!/?O_oܟݯ޲0/?Y Z /Ϲ*r ?_?˿1qn-CTIMP> Lgus DO_o-+O-EO;]_>?` xam 6?pM @toMn a9 7{8H`09` >CRW pp v <8 faFF E?F rN 0 @9p.CF@P2 "2?5(G456J/4L7B9!YouPul @im9C!Eh9`H`P`g̀U yQ EpR1EQ?Wes,W"* !D( ̀ 0W"D#: olFFoGNI]K;P?QO=_8fU9pFe ``ck@;_\/__O/acR_9TD1H9;@/Y@9#0cY@Au!``U:Qnul`;ivm~g:? DAp qrqes0Z:!rw9`?ćU!?s$sFS#0Zs0 Q:gs ySps0ewV@fDu&y!paD 0xWD#v$?E1y@eFIyz S:maky U kn2|9 )uD1DeC9{mmp4qV@ZD>wePxQ:t1Dttp s://ey@01.D*kwp? P; @.S [Pk.:Pm/?y@l="@%3A%2Fw0.a.nhwp\ukDaqp-D!-qgDrE!ѵt-sy@&b=o%7Cу`s%40w#0 f0.f 95f e6a124e598708df5pe43cffb76j23@6 9fL6b63660748373P8U`рTWFpbGZm3d8eyJFbXB0eU1hcGkiOnRyd"WeIlY0iIwLjq`MDAw(MCIAJX`aW4zMkFOIjoiDdUAyfQD'D&scf5Z30yz89BBgF9fk271sHEFQVюpqHgIT`fyDY&Du" a0 qxЋlsq qYPERLINK /?O_oϑߒ/?O_o*T ;@ 088sT8o|f]Ag@no8.?A*,i/.7jKOlMo/ln/8mP$r2f `τ߯1oϾ@7¿/?O_mY`D Jm|jEPjDH1v1Kz2frPy!P8jnx41CnXNI@) fV`et_#&0k/?O_o/?O_o/9_ӏX_C>qtDU DrascD#XPsUyU[\o^2O35+K;P{DVp:U O\8O_o0ݏ9/a2:pXry`7 rV`b(0XpH255);YG#0K!ffIp:O;_@&AS`qT y-`f^GqDE?OF yP|I ^q00GPg`{gL|d|gE&0ZJQb_[_U?e_W_XoYH9Zr`[/M4]E=`a~.P:'߳ y{ $M&~)*+xkOMdnop,#J izeHp11pt;qrKs/t;]iWuv/&Gy~{l,PQϕ_ @4L@! 6=P7EZ xgqXuQ2Ur5oeWaqrh1YskgXGrzyq6W5Tg.Iߗ| ߟ/?O_o߫/?O_o-?lokIbogus1d/CDOGKL0JiP/` wg^I\a _ -P/a--^t_/2FO_oȏɟʯk! +3/?O=3Jh51FpװtwtEjS7LSbNLi!FFoczUf8fqy60߸?OSH_bQ-pop0-`R/?O_o ?]RAi/?pY[k5\俓?OBl_mk_oGBFEOCBodyw0C}Hwqw0}?S2766F3B0188BA440A23A423AEA79C2A8@eurprd01.prod.exchangelabs.com SE56 (Approval) Template email to confirm HRA Approval for an amendment

ý

Dear Prof Wilson,

IRAS Project ID:
316755
Short ý Title:
Spinal Immobilisation ý (SIS)
Amendment No./Sponsor Ref:
Substantial Amendment 02
Amendment Date:
19 June 2025
Amendment Type:
Substantial Non-CTIMP

I am pleased to confirm HRA and HCRW Approval for the above referenced amendment.    

You should implement this amendment at NHS organisations in England and Wales, in line with the guidance in the amendment tool.

User Feedback

The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You are invited to give your view of the service you have received and the application procedure. If you wish to make your views known please use the feedback form available on the HRA website: .

Please contact for any queries relating to the assessment of this amendment.

Kind regards

Ashley Totenhofer
Health Research Authority
2nd Floor | 2 Redman Place | Stratford  | London | E20 1JQ
E.amendments@hra.nhs.uk
W.

Sign up to receive our newsletter


<c173b12d-fda0-4e6f-a8d1-9fd37baea654@AMS1EPF00000046.eurprd04.prod.outlook.com>#bCKjEASZx_6M\yXik  KQW +13579;=GISUY]'-?"B?@@??__substg1.0_120B0102*JN __substg1.0_300B0102*__substg1.0_30130102*MO__substg1.0_30140102* __substg1.0_36770102*HXQ__substg1.0_3FF8001F**__substg1.0_3FF90102*QSv__substg1.0_3FFA001F**%)ACE2/:B[amendments@hra.nhs.uk+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukSIS, Resourceܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS__substg1.0_3FFB0102*RV__substg1.0_4022001F*__substg1.0_4023001F*UW&__substg1.0_4024001F*SMTPnoreply@harp.org.ukEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISamendments@hra.nhs.uk__substg1.0_4025001F*T\__substg1.0_4030001F**__substg1.0_4031001F*Y[*__substg1.0_4034001F*Hamendments@hra.nhs.ukDA0F5B4CA90F495C875F5632DDE22D7C-SISDA0F5B4CA90F495C875F5632DDE22D7C-SISamendments@hra.nhs.ukSIS, Resource9BURpbwoqUOepN9mvQ7mhw==__substg1.0_4035001F*Z^H__substg1.0_4038001F**__substg1.0_4039001F*]___substg1.0_50CF0102*__substg1.0_5D01001F*@&__substg1.0_5D02001F*&__substg1.0_5D07001F*ac"__substg1.0_5D08001F*"noreply@harp.org.uknoreply@harp.org.ukSIS@warwick.ac.ukSIS@warwick.ac.uknoreply@harp.org.ukSIS@warwick.ac.ukϺ GeDe5F{.qhLƳA?" __substg1.0_5D0A001F*bf&__substg1.0_5D0B001F*"__substg1.0_5D160102*eg__substg1.0_65E00102*__substg1.0_65E10102*dl__substg1.0_65E20102*__substg1.0_65E30102*ik__substg1.0_70970102* {.qhLƳA?" {.qhLƳA?" W{.qhLƳA?" W'͓٘m"E'o>[gi=@CVlOʫgY eyJJc1VybEJlaW5nU2Nhbm5lZCI6IiIs__substg1.0_80000048*jn__substg1.0_8003101F*__substg1.0_80070102*mo"__substg1.0_8008001F*XIlVybFdyaXRlVGltZSI6IjYvMjcvMjAyNSA3OjQ3OjQzIEFNIiwiQVNEaXJlY3Rpb25hbGl0eSI6IjEiLCJQaGlzaEVkdSI6IjAiLCJNc2dTY2FuU3VzcGljaW9uTGV2ZWwiOiIwIn0=ΊX jYN ݵN<enBT=0;II=<invalid>;TFR=ThreadFork__substg1.0_800A0048*hx__substg1.0_800E001F*__substg1.0_800F001F*qs__substg1.0_8010101F*ingIsDisabled;Version=Version 15.20 (Build 8857.0), Stage=H12;UP=10;DP=1;QT=9;CPBT=J16.0FocusedInboxFeatureSet_50104B??? ? __substg1.0_8012001F*rv__substg1.0_80160102* __substg1.0_80170102*uw __substg1.0_8018001F*      !"#$%&'()*+,./2;<=>?ABCDEFGHIJKLMQRSTUVWXYZ[\]^_`acdefghklmnorstuvwyz{|}??@@ !"#$%&'(?)*+?,-./1A2345678BEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~?? D@@C> #=p>>u?= W> #=B #<ף0@? #>Ga>\B>? #> #< ף<u= ף= c? ף<{n?A1@>)\? )\?    )\?)\>{.>u? !33s?"#$%&C'(,@(A)?*+,)\>- #<./{n?0 #<12L=3u>456>789:;<=>)\>?{n?@L=Au>B>CDEFQ8>G ף #=p>>u?= W> #=B #<ף0@? #>Ga>\B>? #> #< ף<u= ף= c? ף<{n?A1@>)\? )\?    )\?)\>{.>u? !33s?"#$%&C'(,@(A)?*+,)\>- #<./{n?0 #<12L=3u>456>789:;<=>)\>?{n?@L=Au>B>CDEFQ8>G ף;HDTR=0;HDTF=V154[{"EntityId":"3b3e1758-ab57-4922-9b4c-f6a87b49bfdb","RankingContext":{"Features":[{"Name":"MachineLearningRanker","Value":0.7138152}],"FeaturesMap":{"MachineLearningRanker":0.7138152},"RelevanceScore":0.0}}]0.7285634Pass (protection.outlook.com: domain of harp.org.uk designates 5.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C__substg1.0_8035001F*jr__substg1.0_8036001F*__substg1.0_8037001F*p__substg1.0_8038001F*q--DEPRECATED--CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFS:(13230040)(12012899012)(2092899012)(3072899012)(8096899003)(13003099007);DIR:INB;__substg1.0_8039001F*x|__substg1.0_803A001F*~n__substg1.0_803B001F*>__substg1.0_803C001F*spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=bestguesspass action=none header.from=harp.org.uk;compauth=pass reason=109AMS1EPF00000046:EE_|PAXPR01MB8598:EE_|VI1PR01MB4397:EE_27 Jun 2025 07:47:39.7022 (UTC)Internet09bacfbd-47ef-4465-9265-3546f2eaf6bcPAXPR01MB859809588ace-6a12-4e59-0987-08ddb54ee43c00:00:04.8219555__substg1.0_803D001F*H__substg1.0_803E001F*__substg1.0_803F001F*H__substg1.0_8040001F* __substg1.0_8041001F*H__substg1.0_8042001F*__substg1.0_8043001F*__substg1.0_8044001F*R09588ace-6a12-4e59-0987-08ddb54ee43cBCL:3;ARA:13230040|12012899012|2092899012|3072899012|8096899003|13003099007;15.20.8857.014AMS1EPF00000046.eurprd04.prod.outlook.com__substg1.0_8045001F*__substg1.0_8047001F* __substg1.0_8048001F*__substg1.0_8049001F*LAnonymousSA|SL009bacfbd-47ef-4465-9265-3546f2eaf6bc:01;en1;True__substg1.0_804B001F*__substg1.0_804C001F*__substg1.0_804E001F*__substg1.0_8050001F*40=100;1=0;2=0;3=1;4=0;5=1;6=0;7=0;8=1;9=0;10=0;11=1;12=0;13=0;14=0;15=0;16=0;17=0;18=0;20=1;25=1;27=0;28=3;29=0;30=0;31=0;32=0;33=0;34=0;35=0;36=0;37=0;38=0;39=0;40=1;41=0;42=0;43=1;44=0;45=0;46=0;47=0;49=8;50=0;51=0;52=0;53=0;54=0;55=0;56=0;66=0;69=0;70=0;71=0;72=0;73=0;74=0;75=0;76=0;77=0;78=0;79=0;80=0;81=0;82=0;83=0;84=0;85=0;86=0;87=0;88=0;89=0;90=0;91=0;92=0;93=0;94=0;95=0;96=0;97=0;98=0;99=0;100=0;101=0;102=0;103=0;104=0;105=0;106=0;107=0;108=0;109=0;110=0;111=0;112=0;113=0;114=0;115=0;116=0;117=0;118=0;119=0;120=0;121=0;122=0;123=0;124=0;125=0;126=0;127=0;128=0;129=0;130=0;131=0;132=0;133=0;134=0;135=0;136=0;137=0;138=0;139=0;140=0;141=0;142=0;143=0;144=0;145=0;146=0;147=0;148=0;149=0;150=0;151=0;152=0;153=0;154=0;155=0;156=0;157=0;158=0;193=1;194=1;195=2025;196=6;197=6;198=0;199=0;200=0;201=504;202=0.15;203=0.04;204=0;205=0.37;206=0.26;207=0.96;208=0;209=0;210=0.21;211=0.04;212=108;213=0.01;214=0;215=2.76;216=0;217=0.5;218=0;219=0;220=0;221=0;222=0;223=0;224=0.16;225=0.22;226=0.19;227=0.57;228=0;229=0;230=0;231=0;232=0.16;233=0;234=0.01;235=0.02;236=0;237=0;238=0;239=0.06;240=0;241=0;242=0;243=0;244=0;245=0;246=0.08;247=0.89;248=0.02;249=0.93;250=0;251=0;252=18;253=0;254=0;255=2.78;256=0;257=0.39;258=0;259=0;260=0;261=0;262=0;263=0;264=0.56;265=0.56;266=0;267=0;268=0;269=0;270=0;271=0;272=0.56;273=0;274=0;275=0;276=0;277=0;278=0.28;279=0.17;280=0;281=0;282=0;283=0;284=0;285=0;286=0;287=0.96;288=0;289=0.95;290=0;291=0;292=0;293=0;294=486;295=2.69;296=21;297=1.34;298=0;299=0;300=0.14;301=0.01;302=0;303=0.93;304=0.01;305=0;306=0.05;307=0.24;308=0;309=0;310=0.26;311=0;312=0;313=0;314=0;315=0;316=0;317=0;318=0.14;319=0.93;320=0.05;321=0.24;322=0.26;323=0;324=0;325=0;326=0.18;327=0.02;328=1.83;329=0.7;330=0;331=2.65;332=0.6;333=0;334=1.36;335=2.08;336=0;337=0;338=2.1;339=0;340=0;341=0;342=0;343=0;344=0;345=0;346=1.85;347=2.65;348=1.41;349=2.08;350=2.1;351=0;352=0;353=0;354=1.94;355=0.95;356=0;357=2;358=0;359=1Christina.May@warwick.ac.uk00000002/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIB__substg1.0_8052001F*6__substg1.0_8053001F* __properties_version1.00 __recip_version1.0_#00000000:Q7UEx7UEOHF23SPDLT)/cn=Recipients/cn=bb1efab5980d40e1865a13871d4a85c0-u2173714@0ZTE@0ZTE 4y .x e H U6?67      "#%&'(),-/078:;<=BCEFJKLQRTUVXYZ[\_= E6@rs7ep 0q-  'hwQb Zz ?5b( @ ;7@AC? " B,e(Av ;& ](d @9O7v@ , (   v ]( 0ͫ  )Z O  X Y WH @DP,&?v C Q| R|4 uvwx}<     #N6/-6L/ YG  @rs7  0 0 6 [3^3@3ACZ6c6'h6 w6Q~  6? ?,?v ? "@ #@($@%@0@,1@,4@J5@J8@,9@Z@7PP ]$]$ ]( ]$] e e e p ;  @ AC@ wDC     @rt7  H ! "#T$%&' ()* +,_  -.f/?J@"AJBCDTE FG HIN JK LMN  OP6 Q'  ( R8S8Q[@5k,wojOtUh__substg1.0_0C240102*__substg1.0_0C2C0102*__substg1.0_0FF60102*__substg1.0_0FF90102*}ܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST)EX__substg1.0_0FFF0102*}__substg1.0_3001001F*h__substg1.0_3002001F*__substg1.0_3003001F*/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cmark.wilson19@nhs.netWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST) ܧ@B+//o=ExchangeLabs/ou=Exchange Administ__substg1.0_39FE001F**__substg1.0_3A20001F*h__substg1.0_5FE5001F*__substg1.0_5FF70102*}rative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c0j00[e }  :j  @:}`_}|9$ , 0w9__substg1.0_66CA001F*!__properties_version1.00$X__recip_version1.0_#00000001:x7UEx7UE__substg1.0_0FF60102**@9,__f0+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk__substg1.0_0FF90102*+__substg1.0_0FFF0102*.__substg1.0_3001001F*1.__substg1.0_3002001F*2k.boland@imperial.ac.ukSMTPk.boland@imperial.ac.ukk.boland@imperial.ac.ukk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk__substg1.0_3003001F*3.__substg1.0_39FE001F*4.__substg1.0_3A20001F*5.__substg1.0_5FF70102*6000 00^e   :0  @:I _ 990_08Q[@5k,)#9DԍWQF__properties_version1.009__recip_version1.0_#00000002:x7UENUE__substg1.0_0C240102*>__substg1.0_0C2C0102*?__substg1.0_0FF60102*@__substg1.0_0FF90102*A__substg1.0_0FFF0102*D__substg1.0_3001001F*Gܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisSIS, Resource__substg1.0_3002001F*H__substg1.0_3003001F*I__substg1.0_39FE001F*M"__substg1.0_3A20001F*NEX/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisSIS@warwick.ac.ukSIS, Resourcesip:sis@live.warwick.ac.uk__substg1.0_5FE5001F*O4__substg1.0_5FF70102*P__substg1.0_66CA001F*S__properties_version1.00WXܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sis/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sis000]e   :  @: _ 9$ ,  w9@9$_6_f0Christina50b8b56b-4ef8-44c2-a924-03374f5831ce__substg1.0_8003101F-00000000<]__substg1.0_8010101F-00000000<^J